AI-native congress intelligence
Turn every congress into a competitive edge.
NousCongress captures, structures, and surfaces every strategic signal from ASCO, ESMO, ASH, EHA — built for the decisions that follow.
Designed with pharma medical, HEOR, and CI teams. Cited, evidence-grounded answers in seconds.
The platform
One platform, six purpose-built capabilities.
Everything pharma needs to move from a congress agenda to actionable intelligence.
Smart Filters
Slice every congress the way your team thinks.
Year, conference, session type, therapeutic area, biomarker, therapeutic class. Filters compose. Search is fast. Everything is structured.
- Year · conference · session type
- TA · indication · subtype
- Biomarker · therapeutic class
Trend Dashboards & Heatmaps
Therapy-landscape views, at a glance.
Practice-impact highlights, late-breakers, and real-world evidence — surfaced where decisions get made. Spot crowding the moment a session lands.
- Therapy-landscape heatmap
- Practice-impact highlights
- Late-breakers + AI LBA intelligence brief
OncoTree Navigation
Drill from indication to treatment in one click.
Indication → subtype → line of therapy → treatment. Purpose-built for how oncology decisions actually get made.
- Indication → subtype
- Line of therapy → treatment
- Sessions surfaced at every node
Asset & TA Watchlists
Build watchlists. Plan the congress. Capture insight.
Per asset, per TA, per competitor — as many as your team needs. Pin sessions across tracks. Take notes inline and tag insights to assets, endpoints, and KOLs.
- Per asset · per TA · per competitor
- Schedule + remind across tracks
- Inline notes tagged to assets & KOLs
Auto-Generated Reports
One-click readouts across your watchlist.
Main themes across assets and competitors. Implications for your pipeline. Evidence gaps. One readout per asset, per TA — ready to share with the team.
- Main themes — assets & competitors
- Implications for your pipeline
- Evidence gaps to validate
CongressChat
Ask the congress anything.
Conversational AI grounded in the sessions, abstracts, and trial data of every covered congress. Every answer cited back to the source.
“Which competitor presented combination data in 2L mCRPC this year?”
- Cited, evidence-grounded answers
- TAs, assets, endpoints, trials, RWD
- Seconds, not weeks
Coverage
Live today. Expanding fast.
ASCO 2026 is live with AI LBA synthesis — plus historical and GU datasets for evaluation and planning.
Available today
- ASCO Annual 2026Abstracts, posters, orals, late-breakers · AI LBA intelligence brief (PDF/Word)
- ASCO Annual 2025Full session library · AI summaries · CongressChat
- ASCO GU 2026GU-focused therapy landscape · watchlists · reports
On the roadmap
- ESMOEuropean oncology — full coverage.
- ASH & EHAHematology congresses, both regions.
- TA-specific congressesExpanding by therapeutic area.
Why NouStarX
Built for congress intelligence. Proven at ASCO.
Pharma DNA, NLP DNA, and a working platform.
Presented at ASCO
Pilot platform presented at ASCO 2025.
Peer-reviewed method
A4SLR agentic systematic literature review framework, benchmarked and published in Value in Health — documented, replicable, defensible.
Built for congress workflows
Designed with pharma medical, HEOR, and CI teams. Active use by multiple collaborators.
Let's turn your next congress into your next edge
See NousCongress in action.
30-minute live demo. Walk through the platform with your assets and your competitors — and leave with a sample summary report.